Insulet is a major player when it comes to insulin pump therapy for diabetes. Billerica, Mass.–based Insulet touts its Omnipod system as an easy-to-use tubeless insulin pump. It provides up to three days of non-stop insulin delivery, and users don’t need to handle a needle. Investor demand for the company’s stock is so strong that Insulet announced in November that it was up-sizing a private placement to $350 million in convertible senior notes due in 2024, up from a previous $300 million.
Was going to read this article but refuse to go through multiple clicks to see a list. Can you just give the list?
There’s a link on the opening slide where you can download a full spreadsheet of 100 companies and their stock performance. Hope that helps.